Aurinia Pharmaceuticals Inc - Common Shares (AUPH) by event type
AUPH moves most on analyst downgrades — a median of -1.67% at 30 minutes across 10 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the AUPH overview →
How AUPH reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades 2,504 of 2,603 | 10 | -1.67% | 30% | -2.05% |
| Rating reiterations 2,491 of 3,522 | 19 | -0.09% | 32% | -0.17% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how AUPH usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst downgrades → · Rating reiterations → · AUPH overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| TETRALOGIC PHARMS CORP (TLOG) | 226 | +0.20% | 52% |
| Y-mAbs Therapeutics, Inc. (YMAB) | 226 | -0.20% | 39% |
| Cel-Sci Corporation (CVM) | 224 | -0.54% | 37% |
| OraSure Technologies, Inc. (OSUR) | 224 | -0.17% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.